Brief: Longboard Pharmaceuticals Entered Into Non-Voting Common Stock Purchase Agreement With Investment Fund Affiliated With Farallon Capital Management
26/03/2024 21:39
March 26 (Reuters) - Longboard Pharmaceuticals Inc
LBPH.O :
* LONGBOARD PHARMACEUTICALS - ENTERED INTO NON-VOTING COMMON
STOCK
PURCHASE AGREEMENT WITH INVESTMENT FUND AFFILIATED WITH FARALLON
CAPITAL MANAGEMENT
* LONGBOARD PHARMACEUTICALS INC-PURSUANT TO AGREEMENT, CO
AGREED
TO SELL 2.85 MILLION SHARES OF ITS NON-VOTING COMMON STOCK TO
INVESTOR AT $21.00 PER SHARE
Source text for Eikon: ID:n0000950170-24-036596
Further company coverage: LBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Longboard Pharmaceuticals
See all newsBrief: Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin In Developmental And Epileptic Encephalopathies (DEEs)
Longboard Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
U.S. RESEARCH ROUNDUP- Cadence Design Systems, Equity Bancshares, S&P Global
Deals of the day-Mergers and acquisitions